Serial Number | 98388319 |
Word Mark | POWERING THE FUTURE OF MEDICINE |
Filing Date | Friday, February 2, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Tuesday, June 10, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 1, 2025 |
Goods and Services | Manufacture of materials to the order and specification of others for the cell and gene therapy industry; manufacturing of plasmid DNA, proteins and nucleases, growth media and buffers, and transfection and transduction reagents to the order and specification of others |
Goods and Services | Cytokines and growth factors in the nature of cell culture media for growing, conditioning or differentiating cells for medical or veterinary preparations, specifically in the form of cell or gene therapy products, namely, genetically engineered tissues or cells for medical transplant purposes; human plasma-derived supplements, namely, blood plasma purified into proteins and converted into serums that are used in cell culture and formulation of cell and gene therapy products for medical purposes |
Goods and Services | Biological preparations and reagents for use in industry and science; biological preparations for use in cell cultures other than for medical or veterinary use; reagents for scientific and research use for chemical or biological analysis; plasmid DNA for use in the manufacture of viral vectors, mRNA, and other biologics, namely, biological preparations for use in industry and science; nucleases in the nature of cells for scientific and research purposes; cytokines in the nature of cells and biochemical reagents used in cell culture for scientific and research purposes; growth factors in the nature of cell growth media, and growth media supplemental for growing cells, for use in scientific research; cytokines and growth factors in the nature of cell culture media for growing, conditioning or differentiating cells for use in the manufacture of pharmaceuticals |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 1, 2024 |
Primary Code | 001 |
First Use Anywhere Date | Monday, May 31, 2021 |
First Use In Commerce Date | Monday, May 31, 2021 |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 1, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Monday, May 31, 2021 |
First Use In Commerce Date | Monday, May 31, 2021 |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 1, 2024 |
Primary Code | 040 |
First Use Anywhere Date | Monday, May 31, 2021 |
First Use In Commerce Date | Monday, May 31, 2021 |
Party Name | Akron BioProducts, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Boca Raton, FL 33487 |
Event Date | Event Description |
Tuesday, February 6, 2024 | NEW APPLICATION ENTERED |
Tuesday, August 27, 2024 | ASSIGNED TO EXAMINER |
Wednesday, August 28, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, August 28, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, August 28, 2024 | NON-FINAL ACTION E-MAILED |
Friday, November 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, November 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, November 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, January 2, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Thursday, January 2, 2025 | FINAL REFUSAL E-MAILED |
Thursday, January 2, 2025 | FINAL REFUSAL WRITTEN |
Thursday, January 30, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, January 30, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, January 30, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, January 30, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, March 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, March 24, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Monday, March 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, January 30, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Monday, March 31, 2025 | EXPARTE APPEAL RECEIVED AT TTAB |
Monday, March 31, 2025 | EX PARTE APPEAL-INSTITUTED |
Monday, March 31, 2025 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Wednesday, May 14, 2025 | NON-FINAL ACTION WRITTEN |
Wednesday, May 14, 2025 | NON-FINAL ACTION E-MAILED |
Wednesday, May 28, 2025 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, May 28, 2025 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, May 28, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, May 28, 2025 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, May 28, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, May 28, 2025 | EXPARTE APPEAL TERMINATED |
Wednesday, May 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |